VANCOUVER, BC, Oct. 8, 2024
/CNW/ - CareSpan Health, Inc. (TSXV: CSPN)
("CareSpan" or the "Company") a digital healthcare
company focusing on primary care and mental health through its
provider networks American-APN and American-Med Psych, and its
"Clinic-in-the-Cloud" integrated digital care platform, provides an
update on recent strategic initiatives and announces a leadership
transition.
Strategic Business Shifts and
Updates
U.S. Military Contracts Expansion
CareSpan continues to focus on expanding its network of
providers performing medical examinations for U.S. military
veterans and reservists - a business segment with improved margins.
Despite continued growth in its provider network, a decline in
referral volumes possibly due to federal budget adjustments and
contract management strategies, the Company remains optimistic
about the potential impact of The PACT Act,1 which the
Company expects to drive increased demand for V.A. medical exams
and boost the volume of disability assessments as backlogged claims
are processed.
Golden Care Solutions Partnership
The Company has deepened its collaboration with Golden Care
Solutions, leveraging CareSpan's Clinic-in-the-Cloud™ platform to
support comprehensive preventive services such as Annual Wellness
Visits, Remote Patient Monitoring ("RPM"), and Chronic Care
Management ("CCM"). CareSpan has signed a new agreement with
Golden Care Solutions to expand RPM and CCM services to members of
the American-APN (AAPN) network. This partnership aims to empower
practices nationwide to deliver value-based care and drive better
health outcomes.
Update on ChopraX Transaction
Further to its press releases dated November 7, 2023 and July
8, 2024, the parties have terminated the definitive
agreement entered into between the Company and ChopraX LLC, dated
September 12, 2023. Notwithstanding
the termination, the Company and the team at Chopra intend to
collaborate with respect to utilizing the "Chopra Whole Person
Care" brand in the Company's digital care platform and will
continue working with Dr. Sheila
Patel as Medical Director.
Leadership Transition
CareSpan announces that its Chief Financial Officer,
Leslie Markow, has resigned from her
position as Chief Financial Officer of the Company, effective
September 3, 2024. Ms. Markow is
remaining with the Company on an interim basis as a contractor, to
facilitate a smooth transition of responsibilities to her successor
(once identified). Ms. Markow's contributions have been invaluable,
and her continued involvement will ensure a seamless handover as
CareSpan advances its strategic initiatives.
Outlook and Future Initiatives
CareSpan continues to focus on scaling its digital health
solutions and expanding its provider networks to capture
opportunities in underserved U.S. markets. The strategic talks with
a potential artificial intelligence ("AI") partner are
ongoing, with the goal of aligning CareSpan with AI capabilities
that enhance clinical decision-making and operational
efficiencies.
About CareSpan Health,
Inc.
CareSpan is a healthcare technology and services company.
CareSpan, with its office in British Columbia, is the parent
company of the CareSpan group, which holds a 100% interest in its
operating subsidiary, CareSpan Holdings, Inc.,
a Delaware incorporated company. CareSpan is a healthcare
technology and services company that operates a digital platform
integrating remote patient monitoring, diagnostic tools, patient
electronic health records, and telehealth services. CareSpan's
Clinic-in-the-Cloud™ platform supports both in-person
and virtual care, aiming to improve healthcare access and outcomes
globally.
Forward-Looking
Statements
This news contains "forward-looking statements" within the
meaning of applicable Canadian securities laws (collectively,
"forward-looking statements") which reflect the current
expectations of management of the company's future growth, results
of operations, performance, and business prospects and
opportunities, including the statements made above with respect to:
(i) the Company's opinion on the impact of The PACT Act, and the
resulting increase in demand for V.A. medical services; (ii) the
implications of the expanded services with Golden Care Solutions;
(iii) seamless transition to a new Chief Financial Officer; (iv)
strategic talks with an AI partner to advance the AI capabilities
of the Company and the resulting effects on the Company's
operations; and (v) the intended collaboration with the Chopra
team. Forward-looking statements are frequently, but not always,
identified by words such as "may", "would", "could", "will",
"should", "expect", "plan", "anticipate", "believe", "estimate",
"predict", "potential for", "intend" and similar expressions or the
negative of these terms or other comparable terminology, although
these words may not be present in all forward-looking
statements.
Forward-looking statements are based on management's
assumptions as at the date of the forward-looking statements are
provided, including but not limited to the following: the ability
of the Company to execute its growth plans; the Company's ability
to deliver and generate revenue from the Golden Care Solutions
partnership; the ability of Company's management to execute its
business strategy and deploy capital in an efficient and profitable
manner; no adverse changes in the applicable regulatory environment
of the Company; and Company's ability to sufficiently capture
opportunities to grow. Though management believes that its
assumptions are reasonable in the circumstances, forward-looking
statements involve known and unknown risks, uncertainties and other
factors that may cause the Company's actual results, performance or
achievements to differ materially from all or any of the future
results, performance or achievements expressed or implied by
forward-looking statements.
Risk factors that could cause the Company's actual results,
performance, or achievements to differ from the forward-looking
statements in this news release include, but may not be limited to:
general market and economic risk; the ability of the Company's
management to execute its strategy; the Company's ability to
allocate capital in an efficient manner; the Company may never
reach profitability and has a history of losses; risk of dilution
and further share issuances to raise capital; consumer demand for
remote patient monitoring in the United
States; reliance on key personnel and management; and
unexpected or adverse regulatory changes in the healthcare space.
These factors should be considered carefully, and prospective
investors should not place undue reliance on the forward-looking
statements. Although the forward-looking statements contained in
the news release are based upon what management currently believes
to be reasonable assumptions, the Company cannot assure prospective
investors that actual results, performance or achievements will be
consistent with these forward-looking statements. Except as
required by law, the Company expressly disclaims any intention or
obligation to update or revise any forward-looking statements,
whether as a result of new information, future events or
otherwise.
Neither the TSX Venture Exchange nor its Regulation Service
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
https://www.carespanhealth.com
__________________________________
|
1
|
The Sergeant First
Class Heath Robinson Honoring our Promise to Address Comprehensive
Toxics Act of 2022 ( "The PACT
Act").
|
SOURCE CareSpan Health, Inc.